Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Stürzl

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Aging|November 4, 2015
Cell death inhibition by KSHVVinay Murtadak, Christoph Becker, Michael Stürzl
Advances in Enzyme Regulation|July 12, 2005
Human guanylate binding protein-1 (hGBP-1) characterizes and establishes a non-angiogenic endothelial cell activation phenotype in inflammatory diseasesElisabeth Naschberger, Michael Bauer, Michael Stürzl
International Journal of Molecular Sciences|March 29, 2023
Contribution of Blood Vessel Activation, Remodeling and Barrier Function to Inflammatory Bowel DiseasesNathalie Britzen-Laurent, Carl Weidinger, Michael Stürzl
Biochimica Et Biophysica Acta|December 17, 2013
Validation of the reliability of computational O-GlcNAc predictionRamona Jochmann, Patrick Holz, Heinrich Sticht, et al.
Frontiers in Medicine|August 19, 2021
Angiocrine Regulation of Epithelial Barrier Integrity in Inflammatory Bowel DiseaseMichael Stürzl, Meik Kunz, Susanne M Krug, et al.
Cancers|March 13, 2024
Blood Vessel-Targeted Therapy in Colorectal Cancer: Current Strategies and Future PerspectivesAnne Jacobsen, Jürgen Siebler, Robert Grützmann, et al.
Neoplasia (New York, N.Y.)|March 13, 2017
Noninvasive Bioluminescence Imaging of AKT Kinase Activity in Subcutaneous and Orthotopic NSCLC Xenografts: Correlation of AKT Activity with Tumor Growth KineticsKarina Suchowski, Thomas Pöschinger, Alnawaz Rehemtulla, et al.
International Journal of Cancer|September 19, 2012
Kaposi's sarcoma-derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell lineMichael Stürzl, Dominika Gaus, Wilhelm G Dirks, et al.
World Journal of Gastroenterology|September 9, 2016
Pathophysiological role of guanylate-binding proteins in gastrointestinal diseasesNathalie Britzen-Laurent, Christian Herrmann, Elisabeth Naschberger, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2010
Reverse transfected cell microarrays in infectious disease researchAndreas Konrad, Ramona Jochmann, Elisabeth Kuhn, et al.
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Aging|November 4, 2015
Cell death inhibition by KSHVVinay Murtadak, Christoph Becker, Michael Stürzl
Advances in Enzyme Regulation|July 12, 2005
Human guanylate binding protein-1 (hGBP-1) characterizes and establishes a non-angiogenic endothelial cell activation phenotype in inflammatory diseasesElisabeth Naschberger, Michael Bauer, Michael Stürzl
International Journal of Molecular Sciences|March 29, 2023
Contribution of Blood Vessel Activation, Remodeling and Barrier Function to Inflammatory Bowel DiseasesNathalie Britzen-Laurent, Carl Weidinger, Michael Stürzl
Biochimica Et Biophysica Acta|December 17, 2013
Validation of the reliability of computational O-GlcNAc predictionRamona Jochmann, Patrick Holz, Heinrich Sticht, et al.
Frontiers in Medicine|August 19, 2021
Angiocrine Regulation of Epithelial Barrier Integrity in Inflammatory Bowel DiseaseMichael Stürzl, Meik Kunz, Susanne M Krug, et al.
Cancers|March 13, 2024
Blood Vessel-Targeted Therapy in Colorectal Cancer: Current Strategies and Future PerspectivesAnne Jacobsen, Jürgen Siebler, Robert Grützmann, et al.
Neoplasia (New York, N.Y.)|March 13, 2017
Noninvasive Bioluminescence Imaging of AKT Kinase Activity in Subcutaneous and Orthotopic NSCLC Xenografts: Correlation of AKT Activity with Tumor Growth KineticsKarina Suchowski, Thomas Pöschinger, Alnawaz Rehemtulla, et al.
International Journal of Cancer|September 19, 2012
Kaposi's sarcoma-derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell lineMichael Stürzl, Dominika Gaus, Wilhelm G Dirks, et al.
World Journal of Gastroenterology|September 9, 2016
Pathophysiological role of guanylate-binding proteins in gastrointestinal diseasesNathalie Britzen-Laurent, Christian Herrmann, Elisabeth Naschberger, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2010
Reverse transfected cell microarrays in infectious disease researchAndreas Konrad, Ramona Jochmann, Elisabeth Kuhn, et al.
Pageof 14